Vaxcyte (PCVX) PT Lowered to $130 at BofA Securities

September 28, 2026 6:04 AM

BofA Securities analyst Jason Gerberry lowered the price target on Vaxcyte (NASDAQ: PCVX) to $130.00 (from $133.00) while maintaining a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found